We are delighted to announce two key leadership promotions, elevating staff who have played an integral role in strengthening clinical research and innovating new patient care across cancer types.   K...

Purpose Metastatic triple negative breast cancer has a poor prognosis with limited targeted treatment options. In preclinical studies PI3K inhibition led to increased DNA damage and subsequent sensiti...

The benefit of regional nodal irradiation in the treatment of breast cancer is well established for patients with pathologically positive axillary nodes, but whether it is also beneficial for patie...

future.how is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, future.how has it all. We hope you find what ...

Dr. Mahua Dey is an associate professor in the Department of Neurological Surgery and the director of the surgical neuro-oncology program in the University of Wisconsin School of Medicine and Public Health. She specializes in the surgical management of both benign and malignant brain tumors.

PURPOSEAdjuvant endocrine therapy (ET) improves overall survival (OS) in estrogen receptor (ER)–positive early-stage breast cancer (BC). However, the benefit of ET for those with ER-low BC (ER 1%-10%)...

NIH layoffs delay research benefiting cancer patients, and celebrity cancer news is often missing important information.

In his resignation letter, Peter Marks said his new boss, Robert F Kennedy Jr, favoured

In this statement, ASCO encourages academic medical centers to change their policies and expectations to enhance and promote the professional fulfillment of academic medical oncologists. The statement...

The SMILE study is a multi-institutional phase II clinical trial to determine the efficacy and safety of an antiprogestin, onapristone, in combination…

An abstract is unavailable.